Local accrual pattern of a breast cancer adjuvant chemotherapy clinical trial.

被引：0
|
作者：
Chan, A
Yau, JC
Huan, S
Vergidis, D
Cranston, K
Falkson, C
Dhaliwal, H
机构：
[1] NW Ontario Reg Canc Ctr, Thunder Bay, ON, Canada
[2] Cancercare Manitoba, Winnipeg, MB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
878
引用
下载
收藏
页码：95S / 95S
页数：1
相关论文
共 50 条
  • [21] The OPTION trial of adjuvant ovarian protection by goserelin in adjuvant chemotherapy for early breast cancer
    Leonard, R. C.
    Adamson, D.
    Anderson, R.
    Ballinger, R.
    Bertelli, G.
    Coleman, R. E.
    Fallowfield, L.
    McLinden, M.
    Mansi, J.
    Thomas, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] THE CLINICAL SCIENTIFIC BASIS OF ADJUVANT CHEMOTHERAPY IN BREAST-CANCER
    FISHER, B
    RECENT RESULTS IN CANCER RESEARCH, 1984, 96 : 8 - 17
  • [23] CLINICAL-TRIALS ON ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
    SEMIGLAZOV, VF
    BAVLI, JL
    MOISEYENKO, VM
    RZHANKOV, SV
    MIGMANOVA, NS
    POPOVA, RT
    SELEZNYOV, IK
    KREMEN, BV
    KOSTETSKAYA, TV
    BARASH, NJ
    IVANOVA, OA
    KUCHIERU, AG
    CANCER, 1986, 57 (10) : 1957 - 1960
  • [24] Breast cancer patients' willingness to travel to participate in a clinical trial.
    Zdenkowski, Nicholas
    Lynam, James F.
    Wall, Laura
    Brown, Scott
    Wells, Kathryn
    Sproule, Victoria
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [25] Survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer patients in a randomised trial.
    Kummel, S.
    Krocker, J.
    Kohls, A.
    Breitbach, G-P
    Budner, M.
    Keil, E.
    Hinke, A.
    Blohmer, J-U
    Elling, D.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S113 - S113
  • [26] Fatigue, sleep and circadian rhythms at baseline and after the first adjuvant breast cancer chemotherapy treatment within a randomized control trial.
    Berger, A
    Fischer, P
    Farr, L
    Kuhn, B
    Agrawal, S
    ONCOLOGY NURSING FORUM, 2006, 33 (02) : 464 - 465
  • [27] Goserelin and preservation of ovarian function among breast cancer patients treated with adjuvant cytotoxic chemotherapy: results from a randomised trial.
    Sverrisdottir, A.
    Nystedt, M.
    Fornander, T.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S110 - S110
  • [28] CHEMOTHERAPY INDUCED AMENORRHEA IN A RANDOMIZED TRIAL OF ADJUVANT CHEMOTHERAPY DURATION IN BREAST-CANCER
    REYNO, LM
    LEVINE, MN
    SKINGLEY, P
    ARNOLD, A
    ABUZAHRA, H
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (01) : 21 - 23
  • [29] Feasibility of measuring quality of life in an adjuvant breast trial.
    Moritz, S
    Bellenger, K
    Riley, D
    Houghton, J
    Fallowfield, L
    BRITISH JOURNAL OF CANCER, 1996, 74 : PO24 - PO24
  • [30] A prospective non-randomized clinical trial of adjuvant carboplatin chemotherapy in triple negative breast cancer
    Hamm, C.
    Kulkarni, S.
    Gupta, R.
    Mathews, J.
    Amin, K.
    Hussein, A.
    Porter, L.
    CANCER RESEARCH, 2019, 79 (04)
12345